Detection of Van-positive and negative Vancomycin Resistant Entrococci and their antibacterial susceptibility patterns to the newly introduced antibiotics

Pakistan Journal of Biological Sciences

Volumn 12, Issue 11, 2009, Pages 844-851

  Japoni, A ^a   Farshad, S ^a   Ziyacyan, M ^a   Ziaian, S ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Linezolid; MIC; Tigecycline; Vancomycin resistant enterococci

Indexed keywords

PRIMER DNA;

AGAR GEL ELECTROPHORESIS; ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROCOCCUS; GENETICS; GENOTYPE; HUMAN; IRAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION;

DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; ENTEROCOCCUS; GENOTYPE; HUMANS; IRAN; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS;

EID: 68149144171     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.844.851     Document Type: Article

References (39)

1. Arthur, M. and P. Courvalin, 1993. Genetics and mechanisms of glycopeptide resistance in cntcrococci. Antimicrob. Agents. Chemother., 37:1563-1571.
2. Arthur. M., C. Molinas, F. Depardieu and P. Courvalin, 1993. Characterization of Tnl546. a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faccium BM4I47. J. Bacterid.. 175:117-127.
3. Askarian, M., H.A. Zeinalzadeh. A. Japoni, A. Alborzi and Z.A. Memish, 2009. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) and its antibiotic susceptibility pattern in Namazi hospital healthcare workers in Shiraz, Iran. Int. J. Infect. Dis. 10.1016/j.ijid.2008.11. 026.
4. Centers for Disease Control and Prevention, 1993. Nosocomial enterococci resistant to vancomycin (CDC)-United States, 1989-1993. Morb. Mortal. Wkly. Rep., 42:597-599.
5. Cetinkaya, Y., P. Falk and C.G. Mayhall, 2000. Vancomycin-resistant cntcrococci. Clin. Microbiol. Rev.. 1:686-707.
6. Chang. S., D.M. Sievert, J.C. Hageman, M.L Boulton and F.C. Tenover et al., 2003. Infection with vancomycin resistant Staphylococcus aureus containing the Van A resistance gene. N. Engl. J. Med., 348:1342-1347.
7. Cheng, S., F.K. McCleskey, M.J. Gress, J.M. Petroziello and R. Liu etaL, 1997. A PCR assay for idcniificalion of Enterococcus faecium. J. Clin. Microbiol.. 35:1248-1250.
8. Chou. Y.Y., T.Y. Lin, J.C. Lin, N.C. Wang, M.Y. Peng and F.Y. Chang, 2008. Vancomycin-resislani enterococcal bacteremia comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J. Microbiol. Immunol. Infect., 4:124-129.
9. Clark, N.C, R.C. Cooksey, B.C. Hill, J.M. Swenson and F.C. Tcnovcr, 1993. Characterization of glyeopeptide-resistant enterococci from US hospitals. Antimicrob. Agents Chemother.. 37:2311-2327.
10. Dutka-Malen, S., S. Evers and P. Courvalin, 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant Enterococci by PCR. J. Clin. Microbiol., 33:24-27.
11. Eliopoulos. CM., 1997. Vancomycin-rcsistant enterococci. mechanism and clinical relevance. Infect. Dis. Clin. North. Am.. 11:851-865.
12. Emaneini, M., M. Aligholi and M. Aminshahi. 2008. Characterization of glycopeptides, aminoglycosides and macro] ide resistance among Enterococcus faecalis and Enlerococcus faecium isolates from hospitals in Tehran. Pol. J. Microbiol., 57:173-178.
13. Feizabadi, M.M., S. Asadi, A. Aliahmadi. M. Parvin, R. Parastan, M. Shayegh and G. Etemadi, 2004. Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. Int. J. Antimicrob. Agents., 24:521-522.
14. Flannagan, S.E., J.W. Chow, S.M. Donabcdian, W.J. Brown and M.B. Perri et al., 2003. Plasmid content of a vancomycin-resistant Enlerococcus faecalis isolate from a patient also colonized by Staphylococcus aureus with a VanA phenotype. Antimicrob. Agents. Chemother., 47:3954-3959.
15. Gemmell C.G., 2004. Glycopeptide resistance in Staphylococcus aureus:Is it a real time threat? J. Infect. Chemother. 10:69-75.
16. Gordon, S., J.M. Swenson, B.C. Hill, N.E. Pigott and R.R. Facklam etaL, 1992. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol., 30:2373-2378.
17. Hryniewicz, W., T. Zareba and M. Kawalec, 1998. Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996. Int. J. Antimicrob. Agents., 10:303-307,
18. Kuriyama. T.. D.W. Williams, M. Patel, M.A. Lewis, L.E. Jenkins, D.W. Hill and I.K. Hosein, 2003. Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enlerococcus faecium and Enlerococcus faecalis from a leaching hospital in Wales. J. Med. Microbiol., 52:821-827.
19. Liassine, N., R. Frei, I. Jan and R. Auckenthaler, 1998. Characterization of glycopeptidc-resistant enterococci from a Swiss hospital. J. Clin. Microbiol., 36:1853-1858.
20. Libisch, B.. Z. Lepsanovic. J. Top, M. Muzslay and M. Konkoly-Thege et al., 2008. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. Scand. J. Infect. Dis., 40:778-784.
21. Ligozzi, M. and R. Fontana, 2003. Isolation of total DNA from bacteria and yeast. Afr. J. Biotechnol., 2:251-253.
22. Malani, P.N., L. Thai, S.M. Donabedian, B. Robinson-Dunn and C.A. Kauffman et al., 2002. Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period. J. Antimicrob. Chemother.. 49:841-843.
23. Malsumolo, T.. T. Muratani, K. Okada. M. Shiraishi. T. Hayashida. T. Oki and M. Odawara, 2004. No regional spread of vancomycin-resistant enterococci with VanA or VanB in Kitakyushu. Japan. J. Infect. Chemother.. 10:331-334.
24. McDonald, L.C., M.J. Kuehnert, F.C. Tenover and W.R. Jarvis, 1997. Vancomycin-resistant enterococci outside the health-care setting:Prevalence, sources and public health implications. Emerg. Infect. Dis., 3:311-317.
25. National Committee for Clinical Laboratory Standards Performance of Standard for Antimicrobial Susceptibility Testing, 2004. Fourteenth Information Supplements. NCCLS, Wayne, PA.
26. Nelson. R.R., K.F. McGregor. A.R. Brown, S.G. Amyes and H. Young. 2000. Isolation and characterization of glycopeptidc-resistant enterococci from hospitalized patients over 30 month period. J. Clin. Microbiol.. 38:2112-2116.
27. Palladino, S., I.D. Kay, J.P Flexman, I. Boehm, A.M. Costa, E.J. Lambert and K..I. Christiansen, 2003. Rapid detection of vanA and Van B genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J. Clin. Microbiol., 4:2483-2486.
28. Pangallo, D., H. Drahovskd, J. Harichova\ E. Karelova and K. Chovanova* et al., 2008. Assessment of environmental enterococci bacterial antagonism, pathogenic capacity and antibiotic resistance. Antonie. Van. Leeuwenhoek., 94:555-562.
29. Perlada, D.E., AG. Smulian and M.T. Cushion, 1997. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio:A prospective citywide survey. J. Clin. Microbiol., 35:2342-2347.
30. Satakc. S., N. Clark, D. Rimland. F.S. Nolle and F.C. Tenover, 1997. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J. Clin. Microbiol.. 35:2325-2330.
31. Schaaff, F., A. Reipert and G. Bierbaum. 2002. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Anlimicrob. Agents. Chemother., 46:3540-3548.
32. Talon, D., X. Bertrand and M.T. Houverez, 2001. Risk factors and prevention of the acquisition and transmission of glycopeptide resistant enterococci. Pathol. Biol., 49:641-648.
33. Townsend, M.I., M.W. Pound and R.H. Drew, 2006. Tigycyclinc:New glycocyclinc antimicrobial. Int. Clin. Pract., 12:1662-1667.
34. Turenne, C.Y., D.J. Hoban, J.A. Karlowsky, G.G. Zhanel and A.M. Kabani. 1998. Screening of stool samples for identification of vancomycin-resistant Entcrococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Entcrococcus gallinarum from £. faecium. J. Clin. Microbiol., 36:2333-2335.
35. Turton, J.F., M.E. Kaufmann. J Glover. J.M. Coelho and M. Warner et «/., 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol., 43:3074-3082.
36. Van De Klundert, J.A.M. and J.S. Vliegenthart, 1993. PCR Detection of Genes Coding for Aminoglycoside-Modifying Enzymes. In:Diagnostic Molecular Microbiology:Principles and Applications. Persing, D.H., T.F. Smith. F.C. Tenover and T.J. White (Eds.). American Society for Microbiology, Washington. DC. USA., pp:547-552.
37. Van Den Braak, N., A. Van Bclkum, M. Van Keulcn. J. Vliegenthart, H.A. Verbrugh and H.P. Endtz, 1998. Molecular characterization of vancomvein-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J. Clin. Microbiol.. 36:1927-1932.
38. Woodford, N., C.M. Egelton and D. Morrison, 1997. Comparison of PCR with phenotypic methods for the speciation ofenterococci. Adv. Exp. Med. Biol., 418:405-408.
39. Wu T.L., L.Ma. J.C. Chang. L.H. Su, C. Chu. H.S. Leu and L.K. Siu, 2004. Variable resistance patterns of integron-associated multidrug-resistant Acinetobacter baumannii isolates in a surgical intensive care unit. Microb. Drug. Resist., 10:292-299.